TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy

por McNerney, KO, Karageorgos, S, Ferry, GM, Wolpaw, AJ, Burudpakdee, C, Khurana, P, Toland, CN, Vemu, R, Vu, A, Hogarty, MD, Bassiri, H
Publicado 2022